PFIZER - IntraDay Trade Analysis with Live Signals
← Back to ListKey Parameters
⭐ IntraDay Trade Rating: 3.2
Show all parameters (20 more)
🧾 Trade Setup
Optimal buy price: 4015 ₹. Initial stop-loss at 3975 ₹. Target profit level 1: 4120 ₹ (based on momentum). Target profit level 2: 4200 ₹, but monitor closely for potential reversal; overall, cautiously optimistic given the high volume and recent EPS growth, but a tight stop is crucial to manage risk effectively.
✅ Positive
Immediate volume is elevated relative to the weekly average, indicating potential interest. The recent PAT growth of 6.63% and a robust ROCE of 24.1% suggest continued profitability, which could fuel further upward momentum today.
⚠️ Limitation
[Corrected] Stock P/E (23.7) is actually LOWER than Industry PE (34.8), a discount to industry peers rather than a premium - treat the valuation framing below with that in mind. Despite strong short-term financials, the stock trades at a premium valuation (P/E 23.7 vs Industry PE 34.8), potentially leaving limited room for significant upside and vulnerable to profit-taking if broader market sentiment shifts. The RSI of 17.2 is very low, which could indicate that this may be overbought and a pullback might be imminent.
🏭 Industry
The pharmaceutical sector remains relatively stable, with broad investor confidence driven by ongoing innovation and strong demand for established drugs. However, larger market-wide fluctuations could impact Pfizer’s performance today.